109 / 172
107
(
`
cr)
Note 20 Other current assets
As at
March 31, 2016
As at
March 31, 2015
Unsecured, considered good unless otherwise stated
a) Export incentive receivable
27.87
21.53
b) Mark-to-Market gains on derivatives
3.55
3.34
c) Interest and dividend receivable
0.22
0.11
d) Sundry receivable
Doubtful
0.19
0.19
Less: Provision for doubtful receivable
0.19
0.19
–
–
31.64
24.98
(
`
cr)
Note 21 Revenue from operations
2015-16
2014-15
Sale of products
2,561.69
2,673.34
Sale of services
–
0.90
Other operating revenue:
Export incentives
37.98
34.38
Scrap sales
5.40
5.36
Processing charges
8.30
4.59
2,613.37
2,718.57
Less: Excise duty
154.47
162.92
2,458.90
2,555.65
(
`
cr)
Details of revenue
2015-16
2014-15
Sale of products
Life Science Chemicals
793.51
725.32
Performance and Other Chemicals
1,768.18
1,948.02
2,561.69
2,673.34
(
`
cr)
Note 22 Other income
2015-16
2014-15
Dividend on long-term investments
3.37
1.96
Dividend from subsidiary on long-term investments
7.19
–
Dividend on short-term investments
0.08
0.14
Interest from inter company deposits
–
0.34
Interest from others
3.02
0.72
Lease income
0.20
0.20
Provisions no longer required
6.31
1.62
Provisions for doubtful debts written back
0.24
0.68
Surplus on sale of fixed assets
1.27
1.39
Profit on sale of long-term investment
0.03
–
Exchange rate difference gain (net)
5.21
1.84
Miscellaneous income
18.82
6.42
45.74
15.31
Notes
to the Financial Statements